Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Diabetes: Symptoms, Diagnosis, and Complications

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...

Diabetes Mellitus: Introduction

Diabetes Mellitus: Introduction

Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...

Diabetes Mellitus: Type 2 and Gestational

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...

Type II Diabetes II: Pathophysiology

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.

Diabetes Mellitus: Overview and Type I Subtype

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

Diabetes: Management and Pharmacotherapy

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Structured, Person-Centred Glycaemic Optimisation Before Surgery: The Manchester IP3D Experience.

Clinical medicine (London, England)·2026

Same author

Implementing pharmacogenetic-guided prescribing in general practice: a qualitative process evaluation.

Implementation science communications·2026

Same author

Automated Insulin Delivery Systems in Hospitals: A Systematic Review with Meta-Analysis.

Diabetes technology & therapeutics·2026

Same author

Trends in Potentially Avoidable Hospitalisations Among People With Diabetes in Ireland; 2015-2024.

Diabetes, obesity & metabolism·2026

Same author

Headspace Volatile Organic Compound (VOC) Profiling of Infected and Non-Infected Wound Swabs-A Pilot Study.

Biomolecules·2026

Same author

Correction: Blood glucose testing modalities utilized by people with type 2 diabetes in a secondary care setting.

Irish journal of medical science·2026

Search research articles

Related Experiment Video

Updated: May 25, 2026

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Published on: April 7, 2023

Executive function and diabetes mellitus--a stone left unturned?

Hood Thabit¹, Tommy Kyaw Tun, John McDermott

¹Dept. of Endocrinology, Royal College of Surgeons in Ireland, Connolly Hospital, Blanchardstown, Dublin 15, Ireland.

Current Diabetes Reviews

|January 25, 2012

Summary

Diabetes mellitus (DM) can impair executive function (EF), affecting self-care abilities. Early screening for impaired executive function (IEF) in DM patients is crucial for tailored interventions and better diabetes management.

More Related Videos

Behavioral Assessment of Visual Function via Optomotor Response and Cognitive Function via Y-Maze in Diabetic Rats

Behavioral Assessment of Visual Function via Optomotor Response and Cognitive Function via Y-Maze in Diabetic Rats

Published on: October 23, 2020

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

Published on: February 28, 2013

Related Experiment Videos

Last Updated: May 25, 2026

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Published on: April 7, 2023

Behavioral Assessment of Visual Function via Optomotor Response and Cognitive Function via Y-Maze in Diabetic Rats

Behavioral Assessment of Visual Function via Optomotor Response and Cognitive Function via Y-Maze in Diabetic Rats

Published on: October 23, 2020

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

Published on: February 28, 2013

Area of Science:

Neuroscience
Endocrinology
Cognitive Science

Background:

Diabetes mellitus (DM) is a chronic condition requiring significant patient self-management.
Executive function (EF) governs essential self-care skills like adherence to therapy and lifestyle adjustments.
Emerging evidence indicates impaired executive function (IEF) in DM patients, even with normal overall cognition.

Purpose of the Study:

To highlight the association between diabetes mellitus and impaired executive function.
To discuss potential etiological factors for IEF in DM.
To emphasize the clinical implications of IEF on diabetes self-management and control.

Main Methods:

Review of functional imaging studies (e.g., MRI) implicating frontal and prefrontal cortical systems in EF.
Postulation of cerebral microvascular disease and chronic dysglycaemia as contributors to IEF in DM.
Discussion of available bedside assessment tools for screening IEF.

Main Results:

Diabetes mellitus is linked to impaired executive function (IEF), impacting cognitive skills vital for self-care.
Potential causes of IEF in DM include cerebral microvascular disease and chronic dysglycaemia.
IEF can negatively influence glycemic control and risk factor management in diabetes patients.

Conclusions:

Clinicians should recognize the potential for IEF in diabetes mellitus patients.
Bedside screening tools for IEF show correlation with functional status but require further validation against diabetes self-care assessments.
Targeted behavioral and educational interventions are necessary for managing patients with DM and IEF.